6-Hydroxy-3,4-dihydroquinolin-2(1H)-one: A Key Pharmaceutical Intermediate for Cilostazol Synthesis
Unlocking the potential of advanced chemical synthesis for critical pharmaceutical applications.
Get a Quote & SampleProduct Core Value

6-Hydroxy-3,4-dihydroquinolin-2(1H)-one
This compound serves as a crucial building block in the pharmaceutical industry, most notably as a key intermediate in the synthesis of Cilostazol. Cilostazol is widely used to treat intermittent claudication by improving blood flow, making the reliable supply of this intermediate essential for patient health.
- Explore the detailed chemical synthesis of Cilostazol, understanding how this molecule contributes to its therapeutic efficacy.
- Discover the critical pharmaceutical intermediate 54197-66-9 properties that make it suitable for complex drug manufacturing processes.
- Learn about the precise manufacturing of pharmaceutical intermediates required to ensure the purity and effectiveness of final drug products.
- Understand the importance of sourcing 6-Hydroxy-3,4-dihydroquinolin-2(1H)-one from reliable suppliers to maintain consistent quality in production.
Key Advantages
Reliable Cilostazol Intermediate Synthesis
The compound's well-defined chemical structure and consistent quality ensure efficient and high-yield Cilostazol intermediate synthesis, contributing to cost-effectiveness in drug production.
High Purity for Pharmaceutical Applications
With a guaranteed purity of typically 99%min, this pharmaceutical intermediate meets stringent industry standards, crucial for developing safe and effective medications. The applications of quinolinone derivatives are vast in pharmaceutical research.
Essential Building Block in Organic Synthesis
As a fundamental component in chemical synthesis of Cilostazol, its availability supports the continuous development and production of treatments for cardiovascular conditions.
Key Applications
Pharmaceutical Synthesis
This compound is a cornerstone in the chemical synthesis of Cilostazol, a vital medication for patients suffering from intermittent claudication, highlighting its importance in the medical field.
API Production
Its role as a key API intermediate makes it indispensable for manufacturers producing Active Pharmaceutical Ingredients, ensuring the quality and integrity of the final products.
Research and Development
The unique chemical properties of this quinolinone derivative also make it a subject of interest in ongoing R&D, exploring new potential uses and improvements in pharmaceutical intermediates manufacturing.
Drug Discovery
Its structural features contribute to broader efforts in organic synthesis for drug discovery, potentially leading to the development of novel therapeutic agents beyond Cilostazol.